nach oben

Diabetologia

Erschienen in:

01.08.2005 | Article

Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat

verfasst von: H. Yamada, E. Yamada, A. Higuchi, M. Matsumura

Erschienen in: Diabetologia | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The spontaneously diabetic Torii (SDT) rat has recently been established as a model of type 2 human diabetes mellitus. Male SDT rats develop severe diabetic ocular complications. This study investigated the nature of the ocular complications in this model and addressed the question of whether the SDT rat is a good model of human proliferative diabetic retinopathy.

Methods

Male SDT rats aged 50 weeks were studied for a period of 8 months. Under deep anaesthesia, one eye of each animal was enucleated following perfusion with fluorescein dextran and a retinal flat mount was prepared to study vascular structure. The other eye was enucleated and investigated histologically by haematoxylin–eosin and azan staining and by immunohistochemistry using antibodies against vascular endothelium (Griffonia simplicifolia isolectin B4 antibody) and vascular endothelial growth factor (VEGF).

Results

From the vascular structure study, 17 of 32 rats (53%) showed proliferative retinopathy without vascular non-perfusion. The histological study revealed traction retinal folds in rats with proliferative retinopathy. Azan staining showed some proliferative matrix in rats with normal retinal structure and those with proliferative retinopathy compared with normoglycaemic controls. Staining with Griffonia simplicifolia isolectin B4 antibody showed no specific vascular changes in any of the rats, while VEGF staining revealed higher immunoreactivity in the retina of rats with normal retinal structure and those with proliferative retinopathy, but only low immunoreactivity in the control animals.

Conclusions/interpretation

There appear to be differences between the SDT rat model of diabetic retinopathy and human proliferative diabetic retinopathy, as the SDT rat develops retinal neovascularisation without retinal ischaemia. This very unique display of ocular neovascularisation may be caused by increased expression of VEGF.

Kern T, Kowlulu R, Engerman R (1994) Questions raised by studies of experimental diabetic retinopathy. Elsevier Science, Japan

Kador PF, Takahashi Y, Wyman M, Ferris F III (1995) Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 113:352–354PubMed

Buechi E, Kurosawa A, Tso M (1996) Retinopathy in diabetic hypertensive monkeys: a pathologic study. Graefes Arch Clin Exp Ophthalmol 234:388–398PubMed

Sima AA, Chakrabarti S, Garcia-Salinas R, Basu PK (1985) The BB-rat – an authentic model of human diabetic retinopathy. Curr Eye Res 4:1087–1092

Mansford KR, Opie L (1968) Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 1:670–671CrossRefPubMed

Hanafusa T, Maiyagawa J, Nakajima H et al (1994) The NOD mouse. Diabetes Res Clin Prac 24[Suppl]:S307–S311CrossRef

Peterson R, Shaw M, Neel M-A, Eichberg J (1990) Zucker diabetic fatty rat as model for non-insulin-dependent diabetes melllitus. ILAR News 32:16–19

Berdanier CD (1991) The BHE rat: an animal model for the study of non-insulin-dependent diabetes mellitus. FASEB J 5:2139–2144PubMed

Kuwano K, Hirashima T, Mori S, Saitoh Y, Kurosumi T, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka–Long–Evans–Tokushima Fatty (OLETF) strain. Diabetes 41:1248–1422

10.

Engerman R, Finkelstein D, Aguirre G et al (1982) Ocular complications. Diabetes 31[Suppl 1]:82–88PubMed

11.

Shinohara M, Masuyama T, Shoda T et al (2000) A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 1:89–100PubMed

12.

Smith L, Woesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101–111PubMed

13.

Masuyama T, Komeda K, Hara A et al (2003) Chronological characterization of diabetes development in male spontaneously diabetic Torii rats. Biochem Biophys Res Commun 314:870–877CrossRef

14.

Aiello L, Avery R, Arig P et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487CrossRefPubMed

15.

Adamis A, Miller J, Bernal M-T et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450PubMed

16.

Gerhardinger C, Brown LF, Roy S, Mizutani M, Zucker CL, Lorenzi M (1998) Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am J Pathol 152:1453–1462PubMed

17.

Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E (1996) Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80:241–245PubMed

18.

Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36–47PubMed

19.

Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K (1996) The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819–825PubMed

20.

Sone H, Kawakami Y, Okuda Y et al (1997) Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia 40:726–730CrossRefPubMed

21.

Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G (1998) Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of rat. Diabetes 47:401–406PubMed

22.

Boulton M, Foreman D, Williams G, McLeod D (1998) VEGF localisation in diabetic retinopathy. Br J Ophthalmol 82:561–568PubMed

23.

Pierce E, Avery R, Foley E, Aiello L, Smith L (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92:905–909PubMed

24.

Rand LI, Prud’homme GJ, Ederer F, Canner PL, Group tDRS (1985) Factors influencing the development of visual loss in advanced diabetic retinopathy. Invest Ophthalmol Vis Sci 26:983–991PubMed

25.

Kishi S, Shimizu K (1993) Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology 100:225–229PubMed

26.

Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48–58CrossRefPubMed

Titel: Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat
verfasst von: H. Yamada
E. Yamada
A. Higuchi
M. Matsumura
Publikationsdatum: 01.08.2005
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 8/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-005-1809-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2005

Protein kinase-ζ interacts with munc18c: role in GLUT4 trafficking

Diabetes-associated HLA genotypes affect birthweight in the general population

Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition

Type 1 diabetes in the young: the harvest of sorrow goes on

EASD News Section August 2005

The changing epidemiology of diabetic microangiopathy in type 1 diabetes

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin